GlassScriptPhysician profile
Priya V Ramshesh
NPI 1962484907
$10,753.39
in general payments reported to CMS, 2019-2025
38 companies · $1,747 in 2025
The $1,747 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,451 · 2020: $290 · 2021: $182 · 2022: $2,096 · 2023: $756 · 2024: $3,231 · 2025: $1,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,698 · Food and Beverage: $1,637 · Honoraria: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,697.50 |
| Food and Beverage | $1,637.03 |
| Honoraria | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,989.07 | 2019-2025 | Truqap, Calquence, Enhertu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,641.25 | 2019-2024 | |
| Glaxosmithkline, LLC. | $1,625.00 | 2022 | |
| Daiichi Sankyo INC. | $1,239.12 | 2019-2025 | Vanflyta, Injectafer, Enhertu |
| Merck Sharp & Dohme LLC | $360.77 | 2019-2025 | Keytruda, Welireg, Keytruda Qlex |
| Myriad Genetic Laboratories, INC. | $286.48 | 2022-2024 | Myrisk |
| Cardinal Health 110 LLC | $275.00 | 2025 | |
| Tempus Ai, INC | $245.53 | 2025 | Xt Cdx |
| E.R. Squibb & Sons, L.L.C. | $211.73 | 2019-2023 | |
| Sobi, INC | $200.00 | 2024 | |
| Lilly USA, LLC | $186.97 | 2019-2022 | |
| Pfizer INC. | $167.15 | 2019-2025 | |
| Stryker Corporation | $144.18 | 2025 | Augment Injectable |
| Novartis Pharmaceuticals Corporation | $141.38 | 2019-2024 | |
| Intuitive Surgical, INC. | $139.10 | 2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Ramshesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.